Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2003-12-5
pubmed:abstractText
Adaphostin (NSC 680410), an analog of the tyrphostin AG957, was previously shown to induce Bcr/abl down-regulation followed by loss of clonogenic survival in chronic myelogenous leukemia (CML) cell lines and clinical samples. Adaphostin demonstrated selectivity for CML myeloid progenitors in vitro and remained active in K562 cells selected for imatinib mesylate resistance. In the present study, the mechanism of action of adaphostin was investigated in greater detail in vitro. Initial studies demonstrated that adaphostin induced apoptosis in a variety of Bcr/abl- cells, including acute myelogenous leukemia (AML) blasts and cell lines as well as chronic lymphocytic leukemia (CLL) samples. Further study demonstrated that adaphostin caused intracellular peroxide production followed by DNA strand breaks and, in cells containing wild-type p53, a typical DNA damage response consisting of p53 phosphorylation and up-regulation. Importantly, the antioxidant N-acetylcysteine (NAC) blunted these events, whereas glutathione depletion with buthionine sulfoximine (BSO) augmented them. Collectively, these results not only outline a mechanism by which adaphostin can damage both myeloid and lymphoid leukemia cells, but also indicate that this novel agent might have a broader spectrum of activity than originally envisioned.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcysteine, http://linkedlifedata.com/resource/pubmed/chemical/Adamantane, http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants, http://linkedlifedata.com/resource/pubmed/chemical/Buthionine Sulfoximine, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione, http://linkedlifedata.com/resource/pubmed/chemical/Hydroquinones, http://linkedlifedata.com/resource/pubmed/chemical/NSC 680410, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Quinones, http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species, http://linkedlifedata.com/resource/pubmed/chemical/Tyrphostins, http://linkedlifedata.com/resource/pubmed/chemical/tyrphostin AG957
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4512-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12920036-Acetylcysteine, pubmed-meshheading:12920036-Adamantane, pubmed-meshheading:12920036-Antioxidants, pubmed-meshheading:12920036-Apoptosis, pubmed-meshheading:12920036-Buthionine Sulfoximine, pubmed-meshheading:12920036-DNA, Neoplasm, pubmed-meshheading:12920036-DNA Damage, pubmed-meshheading:12920036-Enzyme Inhibitors, pubmed-meshheading:12920036-Fusion Proteins, bcr-abl, pubmed-meshheading:12920036-Glutathione, pubmed-meshheading:12920036-Humans, pubmed-meshheading:12920036-Hydroquinones, pubmed-meshheading:12920036-K562 Cells, pubmed-meshheading:12920036-Leukemia, pubmed-meshheading:12920036-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:12920036-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:12920036-Leukemia, Myeloid, pubmed-meshheading:12920036-Neoplasm Proteins, pubmed-meshheading:12920036-Neoplastic Stem Cells, pubmed-meshheading:12920036-Quinones, pubmed-meshheading:12920036-Reactive Oxygen Species, pubmed-meshheading:12920036-Tumor Stem Cell Assay, pubmed-meshheading:12920036-Tyrphostins
pubmed:year
2003
pubmed:articleTitle
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells.
pubmed:affiliation
Division of Oncology Research, Guggenheim 1301, Mayo Clinic, 200 First St, SW, Rochester, MN 55901, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't